Navigation Links
Welch Foundation honors Orth as 'rising star' in chemistry

DALLAS Feb. 3, 2010 Dr. Kim Orth, associate professor of molecular biology at UT Southwestern Medical Center, was honored today with the 2010 Norman Hackerman Award in Chemical Research for pioneering work focusing on the mechanisms bacteria use to cause disease.

The Houston-based Welch Foundation, one of the nation's oldest and largest sources of private funding for basic research in chemistry, presents the award annually to honor up-and-coming scientists at Texas institutions. Recipients are recognized for expanding the frontiers of chemistry through their innovative research.

First bestowed in 2002, the award pays tribute to the late Norman Hackerman, a noted scientist and longtime chairman of the foundation's scientific advisory board. At a luncheon on the UT Southwestern campus, Dr. Orth received the $100,000 award and a crystal sculpture.

Dr. Orth has discovered new mechanisms by which invading bacteria hijack and deregulate a cell's signaling systems, cutting off the cell's ability to communicate with other immune-system cells that are needed to fight off disease. Dr. Orth's studies of these mechanisms have important implications in medicine, especially in understanding and potentially treating infectious diseases and immune-related diseases.

"Kim Orth is an original and creative biochemist and a tribute to our institution," said Dr. Daniel K. Podolsky, UT Southwestern president. "Her discovery of novel chemical modifications of proteins by bacteria that enter and kill cells is an important achievement. The groundbreaking advances made by her laboratory provide the foundation for a better understanding of many significant infectious diseases."

With the addition of Dr. Orth, four of the nine Hackerman Award recipients have been UT Southwestern faculty members. Other winners from the medical center are Dr. Xiaodong Wang, professor of biochemistry, in 2003; Dr. Zhijian "James" Chen, professor of molecular biology, in 2005; and Dr. Patrick Harran, former professor of biochemistry, in 2007.

"Kim Orth has already made important contributions to our understanding of how bacteria cause disease and what proteins control signaling in the cell," said Ernest H. Cockrell, chairman of The Welch Foundation. "Her creative, innovative and collaborative research tackles critical questions affecting humankind and lays a solid foundation for building new knowledge. We are pleased to salute her contributions as a young researcher and look forward to further advances from her lab."

Dr. Orth's studies also have uncovered previously unknown mechanisms human cells use to carry out normal functions. For example, she found that an infectious ocean-dwelling bacterium found in oysters and other shellfish kills its host's cells by causing them to burst, providing the invader with a nutrient-rich meal that can then be used to fuel proliferation. The invading pathogen overtakes the host's autophagy, or "self-eating" machinery, a process that is usually tightly controlled.

Understanding how this bacterium commandeers that process led to the discovery of an entirely new way that ATP a molecule that helps provide energy to our cells can alter other molecules. The modification process, which the bacterium exploits in its cell-smashing rampage, is so novel that Dr. Orth's research team created a new name for it: AMPylation.

"There is so much more to learn about the most fundamental mechanisms of life. Investing in basic research now pays dividends decades into the future," Dr. Orth said. "I am incredibly honored to be selected for this award, and I want The Welch Foundation to know how much I appreciate its support for basic science."

Dr. Orth studied psychology at Texas A&M University, but discovered a love for laboratory science after completing a molecular genetics course proctored by Dr. James Wild. She graduated with a degree in biochemistry, and then earned a master's degree from the University of California, Los Angeles.

Dr. Orth received her Ph.D. in biochemistry and molecular biology from UT Southwestern. She joined the UT Southwestern faculty in 2001 as a W.W. Caruth Jr. Scholar in Biomedical Research. In 2003 she was named a Beckman Young Investigator by the Arnold and Mabel Beckman Foundation, and in 2006 she was named a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease.


Contact: Amanda Siegfried
UT Southwestern Medical Center

Related medicine news :

1. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
2. David Welch, Friend, Advocate, Inspiration, Loses Courageous Battle to Brain Tumor
3. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
4. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus
5. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
7. Welch Allyn Expands Network Services Contract With AT&T
8. Jack Welch to Headline the 8th Annual Lean Six Sigma Healthcare Summit
9. Welch Foundation gives $1.6 million for drug discovery research
10. The National Christian Foundation Offers to Match Gifts to Haiti
11. United Nations Foundation Applauds Bill and Melinda Gates for Their Commitment to Vaccinations
Post Your Comments:
(Date:11/25/2015)... ... 25, 2015 , ... On November 25, 2015, officials of Narconon Arrowhead ... the release of a new cutting edge recovery program that has been 50 years ... drug- and alcohol-addicted individuals with the purpose to free addicts from the symptoms and ...
(Date:11/25/2015)... ... ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David Adcock ... , According to court documents, Adcock testified that on May 10, 2010 he sat ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased to ... facial wrinkling. While many patients are aware of the benefits of Botox® in the ... to those suffering with discomfort, soreness, and pain as a result of Jaw Tension, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android app ... new app features a more intuitive SleepScore™ that rates sleep quality on a 100-point ... SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide an ...
(Date:11/25/2015)... , ... November 25, 2015 , ... In an ongoing ... Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its ... surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 at ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
Breaking Medicine Technology: